Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v4-FR
Language French French
Date Updated 2017-12-15 2017-04-03
Drug Identification Number 00854409 00854409
Brand name RATIO-LACTULOSE RATIO-LACTULOSE
Common or Proper name LACTULOSE LACTULOSE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LACTULOSE LACTULOSE
Strength(s) 667MG/ML 667MG/ML
Dosage form(s) BOTTLE BOTTLE
Route of administration ORAL LIQUID ORAL LIQUID
Packaging size 500ML 500ML
ATC code A06AD A06AD
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-07-15 2017-03-01
Estimated end date 2017-11-13 2017-04-30
Actual end date 2017-12-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments